Decision

Allergan Inc. v. Sandoz Canada Inc., 2020 FC 1047 (Silodosin*)

Justice Barnes - 2020-11-10

Read full decision. Automatically generated summary:

This is a motion by the plaintiff ... seeking to enforce what it contends is a partial settlement of this proceeding. ... Because time is of the essence, these reasons will be brief and delivered orally. ... Sandoz contends that its offer to withdraw its counterclaim was, when viewed objectively, only intended to remove its claim to in rem relief and did not affect its invalidity case. ... Based on the foregoing, I have concluded that no agreement was reached by the parties as to the essential terms of a partial settlement so that the extent of the pleadings remain intact.

Decision relates to:

  • T-2023-18 - ALLERGAN INC. v. SANDOZ CANADA INC. ET AL

 

Canadian Intellectual Property